Evidence map›Paper›PMID 28125040›Full record

ReviewMolecules (Basel, Switzerland)2017

Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.

Alessandro Federico, Marcello Dallio, Carmelina Loguercio

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 193 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
193citing papers in PubMed, 4 pooled it
31.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

193 citing papers in PubMed, 4 syntheses or guidelines pooled it, 463 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. The effect of silibinin on liver healing following blunt trauma in rats.Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2026
    Article
  11. Review
  12. Natural Products Targeting Oxidative Stress-Inflammation Crosstalk in Endometriosis.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  13. Article
  14. Review
  15. Article
  16. Iturin derived fromiScience · 2026
    Article
  17. Review
  18. Review
  19. Review
  20. Article

133 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alessandro FedericoDepartment of Clinical and Experimental Medicine, Second University of Naples, 80131 Naples, Italy. alessandro.federico@unina2.it.
Marcello DallioDepartment of Clinical and Experimental Medicine, Second University of Naples, 80131 Naples, Italy. marcello.dallio@gmail.com.
Carmelina LoguercioDepartment of Clinical and Experimental Medicine, Second University of Naples, 80131 Naples, Italy. carmelina.loguercio@unina2.it.
University of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silymarin is the extract of

Indexed as

AnimalsAnti-Inflammatory AgentsAntioxidantsAntiviral AgentsChronic DiseaseHumansLiver DiseasesSilybinSilymarinAnti-Inflammatory AgentsAntioxidantsAntiviral AgentsSilybinSilymarinalcoholic liver diseaseantioxidantshepatocellular carcinomanon-alcoholic fatty liver diseasesilybinsilymarinviral hepatitis

Identifiers

PMID28125040
PMCPMC6155865
OpenAlexW2580291574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.